Physician profile
Robert Frank Lohman
NPI 1144385972
$20,848.05
in general payments reported to CMS, 2019-2025
17 companies · $991 in 2025
The $991 reported for 2025 was more than what 79% of Plastic Surgery Within The Head and Neck providers received nationally (typical 2025 total: $300).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,847 · 2020: $5,352 · 2021: $506 · 2022: $8,633 · 2023: $1,530 · 2024: $988 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,929 · Travel and Lodging: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,928.91 |
| Travel and Lodging | $581.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $16,819.55 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $1,785.26 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Abbvie INC. | $404.99 | 2024-2025 | |
| Innovation Technologies INC | $271.52 | 2022-2025 | Irrisept |
| Mentor Worldwide LLC | $211.73 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $195.68 | 2021 | |
| Checkpoint Surgical, INC | $178.54 | 2020-2023 | Checkpoint Stimulators |
| Aroa Biosurgery Incorporated | $176.42 | 2024 | |
| Heron Therapeutics, INC. | $120.60 | 2022 | |
| Medela LLC | $116.87 | 2019 | |
| Allergan, INC. | $109.88 | 2021 | |
| Medline Industries Lp | $97.11 | 2019 | |
| Alkermes, INC. | $88.86 | 2019 | |
| Biocomposites INC | $84.91 | 2025 | Stimulan |
| Davol INC. | $75.30 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $66.00 | 2024 | |
| Kerecis Limited | $44.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lohman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.